Nebula Research & Development LLC Sells 16,351 Shares of TriMas Co. (NASDAQ:TRS)

Nebula Research & Development LLC reduced its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 40.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,359 shares of the industrial products company's stock after selling 16,351 shares during the quarter. Nebula Research & Development LLC owned 0.06% of TriMas worth $599,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Sterling Capital Management LLC lifted its stake in shares of TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 1,158 shares during the period. JPMorgan Chase & Co. grew its stake in shares of TriMas by 3.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company's stock worth $982,000 after buying an additional 1,227 shares during the last quarter. MetLife Investment Management LLC raised its stake in TriMas by 5.9% during the fourth quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company's stock valued at $610,000 after buying an additional 1,378 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in TriMas by 10.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,993 shares of the industrial products company's stock worth $689,000 after acquiring an additional 2,703 shares in the last quarter. Finally, First Eagle Investment Management LLC increased its holdings in shares of TriMas by 1.8% during the fourth quarter. First Eagle Investment Management LLC now owns 257,506 shares of the industrial products company's stock valued at $6,332,000 after acquiring an additional 4,500 shares in the last quarter. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, BWS Financial restated a "buy" rating and set a $40.00 price objective on shares of TriMas in a research note on Wednesday.

TriMas Stock Performance

Shares of NASDAQ:TRS traded up $0.55 during midday trading on Friday, reaching $24.75. 407,166 shares of the company's stock traded hands, compared to its average volume of 319,868. TriMas Co. has a one year low of $19.33 and a one year high of $28.51. The stock has a 50 day moving average of $22.47 and a 200 day moving average of $24.26. The company has a market cap of $1.01 billion, a price-to-earnings ratio of 38.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83.

TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. The firm had revenue of $241.67 million during the quarter, compared to analyst estimates of $235.41 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.37 earnings per share. As a group, equities research analysts anticipate that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th will be issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Tuesday, May 6th. TriMas's dividend payout ratio is 20.78%.

Insiders Place Their Bets

In other TriMas news, CFO Scott A. Mell sold 2,218 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $22.54, for a total transaction of $49,993.72. Following the completion of the sale, the chief financial officer now owns 26,288 shares of the company's stock, valued at approximately $592,531.52. The trade was a 7.78 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jeffrey A. Fielkow acquired 2,500 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the purchase, the director now directly owns 11,013 shares of the company's stock, valued at approximately $228,850.14. This trade represents a 29.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 929,634 shares of company stock valued at $22,278,549. Insiders own 14.20% of the company's stock.

TriMas Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.